Abbott Laboratories (ABT) Change in Cash (2009 - 2026)

Abbott Laboratories has disclosed Change in Cash across 18 years of filings, most recently posting -$1.7 billion for Q1 2026.

• Change in Cash for Q1 2026 came in at -$1.7 billion, down 58.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $271.0 million (up 9.27% YoY), and the FY2025 annual result was $906.0 million, up 25.83% from the prior year.
• Change in Cash came in at -$1.7 billion for Q1 2026 at Abbott Laboratories, down from $1.0 billion in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $1.3 billion in Q2 2022 to a low of -$2.1 billion in Q1 2022.
• The 5-year median for Change in Cash is $187.0 million (2023), against an average of -$176.2 million.
• Across the five-year window, Change in Cash slumped 274.67% in 2022 and soared 1643.1% in 2025, its largest moves.
• Abbott Laboratories' Change in Cash stood at $288.0 million in 2022, then sank by 35.07% to $187.0 million in 2023, then tumbled by 68.98% to $58.0 million in 2024, then jumped by 1643.1% to $1.0 billion in 2025, then plunged by 270.03% to -$1.7 billion in 2026.
• The last three Change in Cash figures came in at -$1.7 billion (Q1 2026), $1.0 billion (Q4 2025), and $560.0 million (Q3 2025), per Business Quant data.